NCT06740539View on ClinicalTrials.gov

Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs

NANot yet recruitingINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

December 16, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
HFpEF - Heart Failure with Preserved Ejection FractionAtrial Fibrillation (AF)
Interventions
PROCEDURE

Catheter ablation of atrial fibrillation

Catheter ablation of atrial fibrillation

Trial Locations (1)

Unknown

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
collaborator

The Third Affiliated Hospital of Anhui Medical University

UNKNOWN

collaborator

Hefei Second People's Hospital

UNKNOWN

collaborator

The Second People's Hospital of Anhui Province

OTHER

collaborator

Hefei Binhu Hospital

OTHER

lead

Shanghai Chest Hospital

OTHER

NCT06740539 - Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs | Biotech Hunter | Biotech Hunter